206 related articles for article (PubMed ID: 34862752)
1. Predicting infectivity: comparing four PCR-based assays to detect culturable SARS-CoV-2 in clinical samples.
Bruce EA; Mills MG; Sampoleo R; Perchetti GA; Huang ML; Despres HW; Schmidt MM; Roychoudhury P; Shirley DJ; Jerome KR; Greninger AL; Botten JW
EMBO Mol Med; 2022 Feb; 14(2):e15290. PubMed ID: 34862752
[TBL] [Abstract][Full Text] [Related]
2. Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity.
Santos Bravo M; Berengua C; Marín P; Esteban M; Rodriguez C; Del Cuerpo M; Miró E; Cuesta G; Mosquera M; Sánchez-Palomino S; Vila J; Rabella N; Marcos MÁ
J Clin Microbiol; 2022 Jan; 60(1):e0160921. PubMed ID: 34669457
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Ct-values for genomic and subgenomic SARS-CoV-2 RNA reveals limited predictive value for the presence of replication competent virus.
Roesmann F; Jakobsche I; Pallas C; Wilhelm A; Raffel J; Kohmer N; Toptan T; Berger A; Goetsch U; Ciesek S; Widera M
J Clin Virol; 2023 Aug; 165():105499. PubMed ID: 37327554
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19.
Kim JY; Bae JY; Bae S; Cha HH; Kwon JS; Suh MH; Lee HJ; Jung J; Kim MJ; Cui C; Park H; Lee J; Park MS; Kim SH
Clin Microbiol Infect; 2022 Jan; 28(1):101-106. PubMed ID: 34400343
[TBL] [Abstract][Full Text] [Related]
5. Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants.
Despres HW; Mills MG; Shirley DJ; Schmidt MM; Huang ML; Roychoudhury P; Jerome KR; Greninger AL; Bruce EA
Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35058348
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of SARS-CoV-2 subgenomic RT-PCR in a pediatric quaternary care setting.
Osborn LJ; Chen PY; Flores-Vazquez J; Mestas J; Salas E; Glucoft M; Smit MA; Costales C; Dien Bard J
J Clin Virol; 2023 Jul; 164():105494. PubMed ID: 37210881
[TBL] [Abstract][Full Text] [Related]
7. Severe Acute Respiratory Syndrome Coronavirus 2 Normalized Viral Loads and Subgenomic RNA Detection as Tools for Improving Clinical Decision Making and Work Reincorporation.
Santos Bravo M; Nicolás D; Berengua C; Fernandez M; Hurtado JC; Tortajada M; Barroso S; Vilella A; Mosquera MM; Vila J; Marcos MA
J Infect Dis; 2021 Oct; 224(8):1325-1332. PubMed ID: 34329473
[TBL] [Abstract][Full Text] [Related]
8. Quantitative SARS-CoV-2 subgenomic RNA as a surrogate marker for viral infectivity: Comparison between culture isolation and direct sgRNA quantification.
Scutari R; Renica S; Cento V; Nava A; Sammartino JC; Ferrari A; Pani A; Merli M; Fanti D; Vismara C; Scaglione F; Puoti M; Bandera A; Gori A; Piralla A; Baldanti F; Perno CF; Alteri C
PLoS One; 2023; 18(9):e0291120. PubMed ID: 37656746
[TBL] [Abstract][Full Text] [Related]
9. Lack of active SARS-CoV-2 virus in a subset of PCR-positive COVID-19 congregate care patients.
Singh AK; Stellrecht KA; Arunachalam T; Barman TK; Robek MD; Waxman MJ; Elmendorf SL; Metzger DW
J Clin Virol; 2021 Aug; 141():104879. PubMed ID: 34153860
[TBL] [Abstract][Full Text] [Related]
10. Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens.
Chen Z; Ng RWY; Lui G; Ling L; Chow C; Yeung ACM; Boon SS; Wang MH; Chan KCC; Chan RWY; Hui DSC; Chan PKS
Microbiol Spectr; 2022 Apr; 10(2):e0018222. PubMed ID: 35311586
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing.
Ford L; Lee C; Pray IW; Cole D; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie DW; Cherney B; Kirby MK; Fajardo GC; Caudill M; Langolf K; Kahrs J; Zochert T; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker PL; Bonenfant G; Zhou B; Folster JM; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard RP; Killerby ME;
Clin Infect Dis; 2021 Sep; 73(6):e1348-e1355. PubMed ID: 33846714
[TBL] [Abstract][Full Text] [Related]
12. Development of an immunofluorescence assay for detection of SARS-CoV-2.
Atiya-Nasagi Y; Milrot E; Makdasi E; Schuster O; Shmaya S; Simon I; Ben-Shmuel A; Beth-Din A; Weiss S; Laskar O
Arch Virol; 2022 Apr; 167(4):1041-1049. PubMed ID: 35192015
[TBL] [Abstract][Full Text] [Related]
13. Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain Reaction.
Hwang HS; Lo CM; Murphy M; Grudda T; Gallagher N; Luo CH; Robinson ML; Mirza A; Conte M; Conte A; Zhou R; Vergara C; Brooke CB; Pekosz A; Mostafa HH; Manabe YC; Thio CL; Balagopal A
J Infect Dis; 2023 Apr; 227(8):981-992. PubMed ID: 36468309
[TBL] [Abstract][Full Text] [Related]
14. Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.
Phuphuakrat A; Pasomsub E; Srichatrapimuk S; Kirdlarp S; Suksatu A; Srisaowakarn C; Manopwisedjaroen S; Ludowyke N; Purwono PB; Priengprom T; Wongsa A; Thakkinstian A; Hongeng S; Malathum K; Thitithanyanont A; Tassaneetrithep B
Microbiol Spectr; 2022 Jun; 10(3):e0050322. PubMed ID: 35604133
[TBL] [Abstract][Full Text] [Related]
15. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.
Bullard J; Dust K; Funk D; Strong JE; Alexander D; Garnett L; Boodman C; Bello A; Hedley A; Schiffman Z; Doan K; Bastien N; Li Y; Van Caeseele PG; Poliquin G
Clin Infect Dis; 2020 Dec; 71(10):2663-2666. PubMed ID: 32442256
[TBL] [Abstract][Full Text] [Related]
16. Predicting the presence of infectious virus from PCR data: A meta-analysis of SARS-CoV-2 in non-human primates.
Snedden CE; Lloyd-Smith JO
PLoS Pathog; 2024 Apr; 20(4):e1012171. PubMed ID: 38683864
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Virus Culture, Genomic and Subgenomic RNA Load, and Rapid Antigen Test in Experimentally Infected Syrian Hamsters.
Zhang C; Cui H; Guo Z; Chen Z; Yan F; Li Y; Liu J; Gao Y; Zhang C
J Virol; 2022 Sep; 96(18):e0103422. PubMed ID: 36040179
[TBL] [Abstract][Full Text] [Related]
18. Can Testing Predict SARS-CoV-2 Infectivity? The Potential for Certain Methods To Be Surrogates for Replication-Competent Virus.
Binnicker MJ
J Clin Microbiol; 2021 Oct; 59(11):e0046921. PubMed ID: 34346713
[TBL] [Abstract][Full Text] [Related]
19. Viral culture and immunofluorescence for the detection of SARS-CoV-2 infectivity in RT-PCR positive respiratory samples.
Berengua C; López M; Esteban M; Marín P; Ramos P; Cuerpo MD; Gich I; Navarro F; Miró E; Rabella N
J Clin Virol; 2022 Jul; 152():105167. PubMed ID: 35523105
[TBL] [Abstract][Full Text] [Related]
20. An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value.
Sonnleitner ST; Dorighi J; Jansen B; Schönegger C; Gietl S; Koblmüller S; Sturmbauer C; Posch W; Walder G
Virol J; 2021 Apr; 18(1):71. PubMed ID: 33827618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
